Phone: 55 11 5904 7339
Fax: 55 11 5904 7331
Apixaban for Prevention of Acute Ischemic Events – 2: A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban in Subjects with a Recent Acute Coronary Syndrome
A Phase 3, Active Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects with Nonvalvular Atrial Fibrillation
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).
Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia Control in Diabetes.
Trial to Assess the Effects of SCH 530348 in Preventing Heart Attack and Stroke in Patients with Acute Coronary Syndrome.
Brazilian Intervention to Improve the Evidence-based in Routine Practice – Acute Coronary Syndromes
Evaluation of the effect of long infrared radiation, emitted by compression stocking in the adjuvant treatment of Gynoid lipodystrophy (Cellulite)
International Study of Comparative Health Effectiveness with Medical and Invasive Approaches
Surgical Treatment for Ischemic Heart Failure Trial.
A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control on Mono- or Dual Combination Oral Antihyperglycemic Therapy.
Catheter Ablation versus. Antiarrhythmic Drug Therapy for Atrial Fibrillation Trial.
A Phase 3 Trial Comparing Cangrelor to Clopidogrel Standard of Care Therapy in Subjects who require Percutaneous Coronary Intervention.
A multicentre randomized controlled trial of statins attack dose for prevention of cardiovascular complications in high risk noncardiac surgeries.
A randomized, multicentre clinical trial to assess the effect of atorvastatin in patients with acute coronary syndrome and intended percutaneous coronary intervention.
An Open Label Study to Describe the Pharmacokinetics of Cefazolin in Preterm Neonates
Brazilian Cardiovascular Record of Systemic Arterial Hypertension.
A translational approach integrating specific population models of clinical risk, platelet reactivity, biomarkers and tissue metabolomics.
The objective of this patient-level meta-analysis is to evaluate the cardiovascular risk and mortality risk in olmesartan medoxomil-treated patients compared to the risk in patients receiving either placebo or active control drugs using randomized, double blind, controlled trials that meet criteria defined by the FDA.
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patients who have Recently Experience an Acute Coronary Syndrome.